ARS Pharmaceuticals
SPRY----
Forecast & Rating4 analysts currently cover ARS Pharmaceuticals, of which 4 give a positive rating. The average price target is $26.75, about 350.3% upside from the current price of $5.94. Coverage is limited, so the data is for reference only. Data as of Jul 14, 2026; this does not constitute investment advice.
Jul 13, 2026Price forecast
$26.75350.34%
Forecast & RatingStrong buy
4analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast baselineJul 19, 2026
Forecast met25.5%
Stock price$5.94
Average forecast price$26.8
Highest forecast price$32
Lowest forecast price$21
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.